Elena Verzoni Selected Research

Sunitinib (Sutent)

10/2023	Impact of Prior Cytoreductive Nephrectomy on Efficacy in Patients with Synchronous Metastatic Renal Cell Carcinoma Treated with Avelumab plus Axitinib or Sunitinib: Post Hoc Analysis from the JAVELIN Renal 101 Phase 3 Trial.
1/2021	Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib.
8/2019	Role and relevance of quality indicators in the selection of first-line treatment of patients with metastatic renal cell carcinoma: a position paper of the MeetURO Group.
11/2015	TOKIO rationale and protocol: a phase II study to evaluate the activity and safety of third-line tyrosine kinase inhibitor after 2 tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma.
4/2015	Sites of disease as predictors of outcome in metastatic renal cell carcinoma patients treated with first-line sunitinib or sorafenib.
1/2015	Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma.
10/2014	Response to targeted therapy in urachal adenocarcinoma.
4/2014	Axitinib safety in metastatic renal cell carcinoma: suggestions for daily clinical practice based on case studies.
3/2014	Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib.
6/2012	Complete response after sequential sunitinib-sorafenib treatment in a patient with renal cell carcinoma: a case report.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elena Verzoni Research Topics

Disease

93	Renal Cell Carcinoma (Grawitz Tumor) 03/2024 - 01/2007
32	Neoplasms (Cancer) 04/2024 - 03/2012
16	Neoplasm Metastasis (Metastasis) 03/2024 - 01/2014
14	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 10/2015
11	Disease Progression 03/2024 - 01/2007
9	Kidney Neoplasms (Kidney Cancer) 03/2024 - 01/2014
6	Human Influenza (Influenza) 11/2023 - 10/2018
5	Hypertension (High Blood Pressure) 02/2023 - 04/2014
3	Diarrhea 02/2023 - 04/2014
3	Carcinoma (Carcinomatosis) 01/2022 - 06/2012
3	Circulating Neoplastic Cells 02/2020 - 10/2018
2	Stomatitis 02/2023 - 05/2020
2	Hyponatremia 02/2023 - 03/2015
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2022 - 03/2017
2	Fatigue 01/2019 - 04/2014
2	Hypothyroidism 01/2019 - 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 11/2023
1	Neutropenia 02/2023
1	Hand-Foot Syndrome 01/2023
1	Breast Neoplasms (Breast Cancer) 12/2022
1	Lymphoma (Lymphomas) 12/2022
1	Seminoma 01/2022
1	Febrile Neutropenia 01/2022
1	Bone Resorption 12/2021
1	Autoimmune Diseases (Autoimmune Disease) 11/2021
1	Pain (Aches) 10/2020
1	Mucositis 05/2020

Drug/Important Bio-Agent (IBA)

21	Immune Checkpoint InhibitorsIBA 04/2024 - 09/2016
17	cabozantinibIBA 08/2023 - 01/2016
17	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 01/2007
13	Tyrosine Kinase InhibitorsIBA 03/2024 - 01/2014
12	Sunitinib (Sutent)FDA Link 10/2023 - 10/2011
9	Everolimus FDA Link 05/2020 - 11/2011
8	Axitinib (AG 013736)IBA 03/2024 - 11/2011
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2012
8	pazopanib FDA Link 01/2023 - 11/2014
7	tivozanibIBA 01/2024 - 08/2019
6	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2024 - 01/2014
6	NivolumabIBA 08/2023 - 09/2016
4	temsirolimus FDA Link 06/2015 - 11/2011
3	enzalutamideIBA 01/2024 - 11/2018
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 01/2020
3	pembrolizumabIBA 01/2023 - 09/2016
3	CytokinesIBA 01/2023 - 04/2014
3	Hemoglobins (Hemoglobin)IBA 01/2023 - 06/2015
3	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2021 - 10/2018
3	TOR Serine-Threonine KinasesIBA 05/2020 - 01/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 01/2015
3	abirateroneIBA 07/2019 - 06/2016
2	avelumabIBA 03/2024 - 10/2023
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 10/2014
2	Angiogenesis InhibitorsIBA 11/2021 - 01/2014
2	atezolizumabIBA 01/2020 - 09/2016
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2015
2	LigandsIBA 07/2019 - 10/2016
2	Transaminases (Aminotransferases)IBA 01/2019 - 01/2019
2	Abiraterone AcetateIBA 09/2016 - 10/2015
2	Docetaxel (Taxotere)FDA Link 06/2016 - 10/2014
2	Phosphotransferases (Kinase)IBA 05/2016 - 06/2015
2	Irinotecan (Camptosar)FDA LinkGeneric 10/2014 - 01/2009
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2014 - 01/2009
2	Capecitabine (Xeloda)FDA Link 10/2014 - 01/2009
1	Androgen Receptors (Androgen Receptor)IBA 11/2023
1	VaccinesIBA 07/2023
1	Antiviral Agents (Antivirals)IBA 07/2023
1	Creatine Kinase (Creatine Phosphokinase)IBA 02/2023
1	Proton Pump InhibitorsIBA 01/2023
1	pentetreotide (OctreoScan)FDA Link 12/2022
1	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2022
1	99mTc-octreotideIBA 12/2022
1	Octreotide (Sandostatin)FDA LinkGeneric 12/2022
1	EDDA (NiEDDA)IBA 12/2022
1	IpilimumabIBA 10/2022
1	B7-H1 AntigenIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	AndrogensIBA 01/2022
1	DNA Polymerase IIIBA 01/2022
1	Exonucleases (3' 5' Exonuclease)IBA 01/2022
1	AntigensIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2021
1	Thyroid HormonesIBA 01/2021
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021
1	Radium-223IBA 10/2020

Therapy/Procedure

44	Therapeutics 03/2024 - 09/2010
17	Immunotherapy 04/2024 - 09/2016
11	Castration 01/2024 - 10/2015
9	Nephrectomy 03/2024 - 01/2014
4	Drug Therapy (Chemotherapy) 01/2022 - 02/2014
3	Aftercare (After-Treatment) 01/2022 - 01/2018
3	Metastasectomy 11/2019 - 10/2018
2	Radiotherapy 01/2022 - 01/2022
1	Precision Medicine 01/2022
1	Orchiectomy (Orchidectomy) 01/2022
1	Organ Transplantation 11/2021
1	Immunomodulation 01/2021
1	Oral Hygiene (Dental Hygiene) 05/2020